Skip to main content
Clinical Trials/ChiCTR1900026221
ChiCTR1900026221RecruitingUnknown

C 反应蛋白:术后恢复的炎性指标

Not provided1 site in 1 country100 target enrollmentStarted: September 27, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Unknown
Status
Recruiting
Enrollment
100
Locations
1
Primary Endpoint
C-反应蛋白

Study Overview

Brief Summary

探讨术后炎症变化与患者恢复的关系,以期找到一个合适的炎症指标(c-反应蛋白)反映术后恢复情况,帮助患者尽早做出临床干预或出院。

Study Design

Study Type
Other
Primary Purpose
析因分组(即根据危险因素或暴露因素分组)
Masking
N/a

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •择期全麻下行“结直肠癌手术”的患者,年龄>18 岁,ASA 分级 I-III 级。

Exclusion Criteria

  • •术前 3 天感染、有免疫抑制相关疾病。

Arms & Interventions

无并发症组

Intervention: 无并发症组

并发症组

Intervention: 并发症组

Outcomes

Primary Outcomes

C-反应蛋白

并发症

Secondary Outcomes

  • 血常规
  • 肝肾功检查
  • 术后质量恢复量表

Investigators

Sponsor
Not provided

Study Sites (1)

Loading locations...

Similar Trials